pSivida Corp. Stock Nasdaq

Stocks

09/08/16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/07/16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/05/16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/09/15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/09/15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	-2.86%	-0.26%	+51.45%	+110.98%	56.42B
WUXI APPTEC CO., LTD.	-0.34%	+3.51%	+45.55%	+40.16%	44.54B
BIONTECH SE	+0.29%	+6.20%	-14.80%	-19.65%	22.9B
INSMED INCORPORATED	-0.40%	+3.49%	-1.29%	+387.06%	21.21B
WUXI BIOLOGICS (CAYMAN) INC.	-1.42%	+1.78%	+10.43%	-34.63%	16.4B
GENMAB A/S	-1.54%	-1.06%	+7.63%	-39.28%	15.4B
EXELIXIS, INC.	-0.24%	+2.44%	+27.43%	+177.49%	13.35B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.72%	+9.74%	+20.81%	-	12.36B
PHARMAESSENTIA CORPORATION	+0.32%	+2.81%	+96.37%	+213.49%	11.15B
Average	-0.52%	+1.86%	+27.07%	+104.45%	23.75B
Weighted average by Cap.	-0.93%	+2.25%	+30.66%	+96.28%